375.40CHF+2.40%Mkt Cap: 5.63B $P/E: 23.031d ago
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication in Switzerland, Europe, North America, and internationally. The com…
Industry Peers
Medical Instruments & SuppliesIndicators:|
Key Statistics
Company
Market Cap5.63B $
Enterprise Value5.90B $
Revenue (TTM)834.27M $
Gross Profit359.06M $
Net Income (TTM)253.29M $
Revenue/Share61.31 USD
Last Price375.40 CHF
Fiscal Year EndMar 2026
MR QuarterMar 2026
Employees2.0K
CountryCH
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINCH0019396990
Valuation
P/E (Trailing)23.03
P/E (Forward)24.72
PEG3.29
EV/EBITDA15.86
EV/Revenue7.07
P/S6.75
P/B6.35
EPS (TTM)16.31
EPS (Forward)15.19
52W Range
260.5063% of range441.50
52W High441.50 CHF
52W Low260.50 CHF
Profitability
Gross Margin43.04%
Oper. Margin26.45%
EBITDA Margin44.57%
Profit Margin30.36%
ROE29.66%
ROA16.48%
Growth
Revenue Growth-13.30%
Earnings Growth51.70%
Cash Flow & Leverage
Operating CF350.11M $
CapEx (TTM)368.76M $
FCF Margin-7.83%
FCF Yield-1.16%
Net Debt265.02M $
Net Debt/EBITDA0.71
Balance Sheet
Debt/Equity0.35
Current Ratio1.07
Quick Ratio0.73
Book Value/Sh59.15 CHF
Cash/Share2.172 CHF
Dividends
Fwd Div Rate4.400 CHF
Trail. Div Rate4.400 CHF
Div. Yield1.20%
5Y Avg Yield0.55%
Payout Ratio13.50%
Ex-Div DateJul 3, 2026
Pay DateJul 3, 2024
Analyst Consensus
Rating1.8 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)383.85 CHF
Upside (mean)+2.2%
Target Range280.00 CHF – 440.00 CHF
CHF280.00+2.2% to meanCHF440.00
# Analysts13
Ownership
Shares Out.13.15M
Float3.51M
Insiders71.80%
Institutions14.63%
Technical
SMA 50340.50 (+10.2%)
SMA 200315.83 (+18.9%)
Beta0.77
S&P 52W Chg19.63%
Avg Vol (30d)12.24K
Avg Vol (10d)11.77K
Technical Indicators
RSI (14)67.9
MACD7.6817
MACD Signal7.4830
MACD Hist.+0.1987
BB Upper375.15 CHF
BB Middle358.49 CHF
BB Lower341.83 CHF
BB Width9.29%
ATR (14)9.042 CHF
Vol Ratio (20d)1.71x